Genome-wide association analysis of type 2 diabetes in the EPIC-InterAct study
- PMID: 33188205
- PMCID: PMC7666191
- DOI: 10.1038/s41597-020-00716-7
Genome-wide association analysis of type 2 diabetes in the EPIC-InterAct study
Abstract
Type 2 diabetes (T2D) is a global public health challenge. Whilst the advent of genome-wide association studies has identified >400 genetic variants associated with T2D, our understanding of its biological mechanisms and translational insights is still limited. The EPIC-InterAct project, centred in 8 countries in the European Prospective Investigations into Cancer and Nutrition study, is one of the largest prospective studies of T2D. Established as a nested case-cohort study to investigate the interplay between genetic and lifestyle behavioural factors on the risk of T2D, a total of 12,403 individuals were identified as incident T2D cases, and a representative sub-cohort of 16,154 individuals was selected from a larger cohort of 340,234 participants with a follow-up time of 3.99 million person-years. We describe the results from a genome-wide association analysis between more than 8.9 million SNPs and T2D risk among 22,326 individuals (9,978 cases and 12,348 non-cases) from the EPIC-InterAct study. The summary statistics to be shared provide a valuable resource to facilitate further investigations into the genetics of T2D.
Conflict of interest statement
The authors declare no competing interests.
Figures




References
-
- International Diabetes Federation. IDF Diabetes Atlas, 9th edn. https://www.diabetesatlas.org (2019).
-
- Mahajan A, et al. Fine-mapping of an expanded set of type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps Individual study design and principal investigators Europe PMC Funders Group. Nat. Genet. 2018;50:1505–1513. doi: 10.1038/s41588-018-0241-6. - DOI - PMC - PubMed